Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122980492 | 12298049 | 2 | F | 20110602 | 20160411 | 20160422 | 20160725 | PER | US-ASTRAZENECA-2016SE39104 | ASTRAZENECA | 27588.00 | DY | M | Y | 55.30000 | KG | 20160725 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122980492 | 12298049 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
| 122980492 | 12298049 | 2 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122980492 | 12298049 | 1 | Blood cholesterol |
| 122980492 | 12298049 | 2 | Blood cholesterol |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122980492 | 12298049 | Aneurysm | |
| 122980492 | 12298049 | Product use issue | |
| 122980492 | 12298049 | Stent-graft endoleak | |
| 122980492 | 12298049 | Ulcer | |
| 122980492 | 12298049 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |